Characterization of MW06, a human monoclonal antibody with cross-neutralization activity against both SARS-CoV-2 and SARS-CoV

• Main Authors: Wen Jiang (Author), Junchao Wang (Author), Shasha Jiao (Author), Chenjian Gu (Author), Wei Xu (Author), Ben Chen (Author), Rongjuan Wang (Author), Huilin Chen (Author), Youhua Xie (Author), An Wang (Author), Gang Li (Author), Dadi Zeng (Author), Jinchao Zhang (Author), Min Zhang (Author), Shuang Wang (Author), Mingzhu Wang (Author), Xun Gui (Author)
• Format: Book
• Published: Taylor & Francis Group, 2021-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The global pandemic of COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in widespread social and economic disruption. Effective interventions are urgently needed for the prevention and treatment of COVID-19. Neutralizing monoclonal antibodies (mAbs) have d...